The estimated Net Worth of Stephen From is at least $38.8 Million dollars as of 11 July 2019. Mr. From owns over 127,355 units of AB Active ETFs Inc stock worth over $38,180,556 and over the last 10 years he sold EYEG stock worth over $30,565. In addition, he makes $601,340 as President, Chief Executive Officer, and Director at AB Active ETFs Inc.
Sign up
Mr. From EYEG stock SEC Form 4 insiders trading
Stephen has made over 4 trades of the AB Active ETFs Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 127,355 units of EYEG stock worth $30,565 on 11 July 2019.
The largest trade he's ever made was selling 127,355 units of AB Active ETFs Inc stock on 11 July 2019 worth over $30,565. On average, Stephen trades about 4,330 units every 23 days since 2015. As of 11 July 2019 he still owns at least 1,032,465 units of AB Active ETFs Inc stock.
You can see the complete history of Mr. From stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Stephen From biography
Stephen From serves as President, Chief Executive Officer, Director of the Company. He has served as our President, Chief Executive Officer, and director since October 2005. Mr. From was formerly the Chief Financial Officer at Centelion SAS, an independent biotechnology subsidiary of Sanofi-Aventis. Prior to this, Mr. From spent several years as an investment banker specializing in the biotechnology and medical device sectors. He served as Director in the Global Healthcare Corporate and Investment Banking Group and Head of European Life Sciences for Bank of America Securities. Mr. From holds a BSc from the University of Western Ontario, an accounting diploma from Wilfred Laurier University and has qualified as a Chartered Accountant in Ontario, Canada.
What is the salary of Stephen From?
As the President, Chief Executive Officer, and Director of AB Active ETFs Inc, the total compensation of Stephen From at AB Active ETFs Inc is $601,340. There are no executives at AB Active ETFs Inc getting paid more.
How old is Stephen From?
Stephen From is 56, he's been the President, Chief Executive Officer, and Director of AB Active ETFs Inc since 2018. There are 5 older and 3 younger executives at AB Active ETFs Inc. The oldest executive at AB Active ETFs Inc is Morton Goldberg, 82, who is the Independent Director.
What's Stephen From's mailing address?
Stephen's mailing address filed with the SEC is C/O EYEGATE PHARMACEUTICALS, INC., 271 WAVERLEY OAKS ROAD, SUITE 108, WALTHAM, MA, 02452.
Insiders trading at AB Active ETFs Inc
Over the last 10 years, insiders at AB Active ETFs Inc have traded over $15,523,641 worth of AB Active ETFs Inc stock and bought 17,254,349 units worth $18,625,708 . The most active insiders traders include Capital, Llc Armistice Capi..., Peter Greenleaf, and (Innoven Partenaires S.A.) .... On average, AB Active ETFs Inc executives and independent directors trade stock every 60 days with the average trade being worth of $19,985,138. The most recent stock trade was executed by Capital, Llc Armistice Capi... on 30 July 2021, trading 260,963 units of EYEG stock currently worth $647,188.
What does AB Active ETFs Inc's logo look like?
Complete history of Mr. From stock trades at AB Active ETFs Inc
AB Active ETFs Inc executives and stock owners
AB Active ETFs Inc executives and other stock owners filed with the SEC include:
-
Stephen From,
President, Chief Executive Officer, Director -
Michael Manzo,
Vice President - Engineering -
Sarah Romano,
Chief Financial Officer -
Paul Chaney,
Independent Chairman of the Board -
Praveen Tyle,
Independent Director -
Thomas Hancock,
Independent Director -
Bernard Malfroy-Camine,
Independent Director -
Morton Goldberg,
Independent Director -
Keith Maher,
Director -
Steven Boyd,
Director -
Brenda Mann,
VP of Research & Development -
Michael Garanzini,
Chief Commercial Officer -
Peter Greenleaf,
Director -
Barbara Wirostko,
Chief Medical Officer -
(Innoven Partenaires S.A.) ...,
10% owner -
Private Equity Natixis,
10% owner -
Thomas Balland,
Director -
Ventech B Fcpr,
10% owner -
Capital Ii Ventech,
10% owner -
Mounia Chaoui,
Director -
Ryan Randall Brenneman,
Chief Financial Officer -
Franz Obermayr,
Acting CEO -
Kenneth L Gayron,
Director -
Aron Shapiro,
Director -
Brian M. Strem,
President and CEO